Model Number UNKNOWN |
Device Problems
Mechanical Problem (1384); Insufficient Information (3190)
|
Patient Problems
Hyperglycemia (1905); Coma (2417)
|
Event Type
Injury
|
Manufacturer Narrative
|
If device is returned, evaluation will be performed to determine if a malfunction has occurred.This is an initial report.A follow-up report will be submitted when the final evaluation is completed.
|
|
Event Description
|
Lilly case id: (b)(4).This report is associated with product complaint: (b)(4).This spontaneous case, reported by a pharmacist who contacted the company to report adverse events and product complaint, concerned a male patient of an unknown age, and origin.Medical history and concomitant medication were not provided.The patient received human insulin (rdna origin) injections (humulin r 100 units/ml), via a cartridge in a reusable pen (humapen savvio,unknown colour), at an unknown dose, route and frequency for an unknown indication, started on an unknown date.On an unknown date, while on human insulin therapy, his insulin pen was not loading properly (pc (b)(4), lot number unknown).On an unknown date, he had gone to diabetic coma because of not getting his insulin (unspecified reason).The event was considered as serious by the company due to their medical significance.Information regarding the corrective treatment, outcome of the events and the status of human insulin therapy was not provided.The patient was the operator of the humapen savvio device, and his training status was not provided.The general device model duration of use and the suspect device duration of use was not provided.The action taken with the suspect device was not provided and device was available for return.The reporting consumer did not provide the relatedness assessment of the events to the human insulin therapy and humapen savvio device.Edit 09jan2024: updated medwatch and european and canadian (eu/ca) fields for expedited device reporting.No new information added.
|
|
Manufacturer Narrative
|
B.5.Narrative field: new, updated, and corrected information is referenced within the update statements in b.5.Please refer to update statement(s) dated 19jan2024 in the b.5.Field.Evaluation summary a pharmacist reported on behalf of a male patient that the patient's humapen savvio was "was not loading properly and that the pen body is faulty." the device was not returned to the manufacturer for investigation (batch unknown).Therefore, it could not be evaluated to confirm the complaint or presence of a malfunction.Malfunction unknown.All humapen savvio devices are assessed for injection screw travel at the end of the manufacturing process, thus ensuring device functionality with high probability.There is no evidence of improper use or storage.
|
|
Event Description
|
Lilly case id: (b)(6) this report is associated with product complaint: (b)(4) this spontaneous case, reported by a pharmacist who contacted the company to report adverse events and product complaint, concerned a male patient of an unknown age, and origin.Medical history and concomitant medication were not provided.The patient received human insulin (rdna origin) injections (humulin r 100 units/ml), via a cartridge in a reusable pen (humapen savvio, unknown colour), at an unknown dose, route and frequency for an unknown indication, started on an unknown date.On an unknown date, while on human insulin therapy, his insulin pen was not loading properly (pc 6877941, lot number unknown).On an unknown date, he had gone to diabetic coma because of not getting his insulin (unspecified reason).The event was considered as serious by the company due to their medical significance.Information regarding the corrective treatment, outcome of the events and the status of human insulin therapy was not provided.Humapen savvio did not return to manufacturer.The patient was the operator of the humapen savvio device, and his training status was not provided.The general device model duration of use and the suspect device duration of use was not provided.The action taken with the suspect device was not provided and device was available for return.The reporting consumer did not provide the relatedness assessment of the events to the human insulin therapy and humapen savvio device.Edit 09jan2024: updated medwatch and european and canadian (eu/ca) fields for expedited device reporting.No new information added.Edit 10-jan-2023: upon internal review of information received on 14-dec-2023, updated device from humapen savvio red to humapen savvio (unknown color) and update pc number.Update 19jan2024: additional information received on 17jan2024 from the global product complaint database.Entered the device specific safety summary (dsss); updated the medwatch and european and canadian (eu/ca) device fields, for the suspect device humapen savvio unknown colour associated with (b)(4).Corresponding fields and narrative updated accordingly.
|
|
Search Alerts/Recalls
|
|